The Lancet Microbe 2024

4 papers
In 2024, research published in *The Lancet Microbe* focused on the genomic characterization of bacterial pathogens and the mechanisms of antimicrobial resistance. A portion of the year's work addressed *Mycobacterium tuberculosis*, specifically investigating the genetic basis of bedaquiline resistance in South African isolates and identifying bacterial determinants that influence infection and treatment outcomes through phenogenomic analysis. These studies indicate a focus on using high-resolution genomic data to address clinical challenges in tuberculosis management. Other research included studies on nosocomial infections and broader trends in drug resistance. One prospective cohort study utilized pan-pathogen deep sequencing to monitor bacterial pathogens in Italian hospitals during early 2020. Additionally, the journal published updates regarding the global state of antimicrobial resistance. Prolific contributors to these themes included researchers such as Derrick W. Crook, Zamin Iqbal, and Leah W. Roberts, reflecting a focus on genomic surveillance and the molecular epidemiology of infectious diseases.

Top Authors

AuthorPapers
Antti Honkela1

Papers

Title
Antimicrobial resistance: a concise update
Identification of bacterial determinants of tuberculosis infection and treatment outcomes: a phenogenomic analysis of clinical strains
MmpR5 protein truncation and bedaquiline resistance in Mycobacterium tuberculosis isolates from South Africa: a genomic analysis
Pan-pathogen deep sequencing of nosocomial bacterial pathogens in Italy in spring 2020: a prospective cohort study